Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT03520920
Status:
COMPLETED
Last Update Posted:
2024-10-26
First Post:
2018-04-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-28
First Submit QC Date:
None
Study First Post Date:
2018-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-26
Results First Submit QC Date:
None
Results First Post Date:
2021-10-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL